TORONTO, 19 août 2026 (GLOBE NEWSWIRE) — Le directeur national du Syndicat des Métallos, Marty Warren, a fait la déclaration suivante concernant le report de l’application des nouveaux tarifs américains de 50 % sur les produits canadiens et les négociations commerciales en cours entre le Canada et les États-Unis :
Category: News
News
-
Investissements Purpose annonce les distributions d'août 2026
TORONTO, 18 août 2026 (GLOBE NEWSWIRE) — Investissements Purpose (« Purpose ») a le plaisir d’annoncer des distributions pour le mois d’août 2026 pour ses fonds négociés en bourse à capital variable et ses fonds à capital fixe (les « fonds »).
Originally published via Source Article.
-
Purpose Investments Inc. Announces August 2026 Distributions
Purpose is pleased to announce distributions for the month of August 2026 for its open-end exchange traded funds and closed-end funds.
Originally published via Source Article.
-
Hampton Financial Corporation Issues Stock Options
TORONTO, Aug. 18, 2026 (GLOBE NEWSWIRE) — Hampton Financial Corporation (“Hampton” or the “Company”) (TSXV:HFC) today announced that it has issued fully vested stock options to purchase up to an aggregate of 3,050,000 subordinate voting shares of the Corporation at the price of $0.35 per share for a ten year term. The stock options are subject to approval of the Company’s amended stock option plan by the TSXV and shareholders of the Company.
Originally published via Source Article.
-
JR Wealth Management Launches New Reputation Protection and Strategic Response Service
An analysis of online defamation, its professional and personal impact, and strategic approaches to protecting and rebuilding digital reputation.
Originally published via Source Article.
-
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built
Originally published via Source Article.